October 2012

La Vanguardia publishes an opinion article on research, by the IDIBELL general manager

Leave a Comment / Innovation / By

The newspaper La Vanguardia publishes on Sunday, October 7th, an opinion article written by the IDIBELL general manager, Emilià Pola, on the future of the research and development in the world and in Catalonia. Pola highlights that “every biomedical researcher makes possible a business of 400,000 euros per year, five times more than it costs”. […]

La Vanguardia publishes an opinion article on research, by the IDIBELL general manager Read More »

IDIBELL leads a European project on developing strategies against liver disease

Leave a Comment / Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, TGF-beta and cancer / By

IT-LIVER is a 3.3-million Euros project funded by European Commission under its FP7 Marie Curie Actions. This project will be carried out by 8 academic-research institutions and 4 industrial partners from six European countries. The coordinator of IT-LIVER is Isabel Fabregat, head of the Biological clues of the invasive and metastatic phenotype group of the

IDIBELL leads a European project on developing strategies against liver disease Read More »

The MED12 oncogene, key in response to cancer drugs

Leave a Comment / Cancer, Colorectal Cancer, Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell / By

The MED12 oncogene is essential in monitoring response to new cancer drugs, according to the study published in Cell and leaded by researchers at the IDIBELL and ICO in collaboration with researchers from the Netherlands Cancer Institute (NKI) in Amsterdam. This research, published in Cell, has shown that MED12 oncogene plays a key role in

The MED12 oncogene, key in response to cancer drugs Read More »

Animal models developed by researchers at IDIBELL and ICO can revolutionize the study of cancer

Leave a Comment / Breast cancer, Cancer, Colorectal Cancer, Hereditary cancer , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Tumor and stromal chemoresistance  / By

Some animal models developed by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Catalan Institute of Oncology (ICO) has served to validate the effectiveness of a new drug against ovarian cancer resistant to cisplatin. The multidisciplinary work, done in collaboration with the biopharmaceutical company Pharmamar, was published in the journal Clinical

Animal models developed by researchers at IDIBELL and ICO can revolutionize the study of cancer Read More »

Clément François: “We must promote music in children”

Leave a Comment / Cognition and Brain Plasticity, Neuroscience Area, Neuroscience Program / By

Last October 5th took place in the University of Barcelona (Bellvitge Campus) the conference “Musical practice for the development of speech segmentation abilities, behavioural and electrophysiological evidences”, by PhD. Clément François, researcher of the Institut de Neurosciences de la Méditerranée CNRS and Aux-Marseille Universities (France). The Cognition and Brain plasticity group, from the UB and

Clément François: “We must promote music in children” Read More »

Aging and epigenetics in “Divendres” (TV3)

Leave a Comment / Cancer Epigenetics / By

New advances in anti-aging research attended the “Divendres” program on TV3 last October 3. After an introduction about aging and how our habits determined up to 90% of our life, the journalist Xavi Coral talked with Dr. Manel Esteller, director of the Cancer Epigenetics and Biology Program in the Bellvitge Biomedical Research Institute (IDIBELL), Professor

Aging and epigenetics in “Divendres” (TV3) Read More »

UPC and IDIBELL researchers patent a virtual guided-bronchoscopy system to help diagnose lung cancer

Leave a Comment / Cardiovascular, Respiratory and Systemic Diseases and cellular aging Program, Pneumology , Translational Medicine Area / By

A team of researchers from the Institute of Industrial and Control Engineering (IOC) of the Universitat Politècnica de Catalunya · BarcelonaTech (UPC) and the Pulmonology Research Group of the Bellvitge Biomedical Research Institute (IDIBELL) has patented an improved virtual bronchoscopy system designed to enhance endoscopic examination of peripheral lung lesions, that is, small nodules located

UPC and IDIBELL researchers patent a virtual guided-bronchoscopy system to help diagnose lung cancer Read More »

Adult stem cells change their epigenome to generate new organs

Leave a Comment / Cancer Epigenetics / By

The team led by Manel Esteller, director of the Cancer Epigenetics and Biology Program in the Bellvitge Biomedical Research Institute (IDIBELL), Professor of Genetics at the University of Barcelona and ICREA researcher, has identified epigenetic changes that occur in adult stem cells to generate different body tissues. The finding is published this week in The

Adult stem cells change their epigenome to generate new organs Read More »

Scroll to Top